PLoS ONE, ISSN 1932-6203, 12/2017, Volume 12, Issue 12, p. e0190027
Objectives Sleep-wake disturbances (SWD) are frequent in Parkinson’s disease (PD). The effect of deep brain stimulation (DBS) on SWD is poorly known. In this...
Brain | Parkinson's disease | Deep brain stimulation | Parkinsons disease | Solitary tract nucleus | Stimulation | Electroencephalography | Neurosurgery | Mental depression | Electrodes | Apathy | Surgery | Sleepiness | Sleep and wakefulness | Movement disorders | Vigilance | Emotional behavior | Neurodegenerative diseases | Fatigue | Data processing | Patients | Quality of life | Neurology | Sleep | Hospitals | Correlation analysis | Disturbances
Brain | Parkinson's disease | Deep brain stimulation | Parkinsons disease | Solitary tract nucleus | Stimulation | Electroencephalography | Neurosurgery | Mental depression | Electrodes | Apathy | Surgery | Sleepiness | Sleep and wakefulness | Movement disorders | Vigilance | Emotional behavior | Neurodegenerative diseases | Fatigue | Data processing | Patients | Quality of life | Neurology | Sleep | Hospitals | Correlation analysis | Disturbances
Journal Article
Neurology, ISSN 0028-3878, 09/2016, Volume 87, Issue 13, pp. 1407 - 1416
BACKGROUND:Sleep-disordered breathing (SDB) and sleep-wake disturbances (SWD) are highly prevalent in stroke patients. Recent studies suggest that they...
DAYTIME SLEEPINESS | APNEA | RISK-FACTORS | RESTLESS LEGS SYNDROME | CARDIOVASCULAR EVENTS | ACUTE ISCHEMIC-STROKE | FOLLOW-UP | POSITIVE AIRWAY PRESSURE | ADAPTIVE SERVO-VENTILATION | ASSOCIATION | CLINICAL NEUROLOGY | Sleep Apnea Syndromes - epidemiology | Humans | Stroke - diagnosis | Sleep Wake Disorders - therapy | Stroke - complications | Sleep Wake Disorders - diagnosis | Sleep Wake Disorders - complications | Sleep Apnea Syndromes - complications | Sleep Apnea Syndromes - diagnosis | Sleep Wake Disorders - epidemiology | Stroke - epidemiology | Sleep Apnea Syndromes - therapy | Stroke - therapy | 244 | 246 | 247 | 250 | Views and Reviews
DAYTIME SLEEPINESS | APNEA | RISK-FACTORS | RESTLESS LEGS SYNDROME | CARDIOVASCULAR EVENTS | ACUTE ISCHEMIC-STROKE | FOLLOW-UP | POSITIVE AIRWAY PRESSURE | ADAPTIVE SERVO-VENTILATION | ASSOCIATION | CLINICAL NEUROLOGY | Sleep Apnea Syndromes - epidemiology | Humans | Stroke - diagnosis | Sleep Wake Disorders - therapy | Stroke - complications | Sleep Wake Disorders - diagnosis | Sleep Wake Disorders - complications | Sleep Apnea Syndromes - complications | Sleep Apnea Syndromes - diagnosis | Sleep Wake Disorders - epidemiology | Stroke - epidemiology | Sleep Apnea Syndromes - therapy | Stroke - therapy | 244 | 246 | 247 | 250 | Views and Reviews
Journal Article
2007, Lung biology in health and disease, ISBN 0849337151, Volume 220, xxviii, 697
Compiled by an international group of more than 40 authors, this reference book supplies an engaging and comprehensive review of the major topics and key...
Hypersomnia | Narcolepsy | Hypersomnolence, Idiopathic | Kleine-Levin Syndrome | Neurology | Sleep Medicine | Pulmonary Medicine
Hypersomnia | Narcolepsy | Hypersomnolence, Idiopathic | Kleine-Levin Syndrome | Neurology | Sleep Medicine | Pulmonary Medicine
Book
Cerebrovascular Diseases, ISSN 1015-9770, 02/2015, Volume 39, Issue 2, pp. 102 - 109
Background and Purpose: Precise mechanisms underlying the effectiveness of the stroke unit (SU) are not fully established. Studies that compare monitored...
Original Paper | Stroke unit | Mobile stroke system | Intensive care unit | Acute management of stroke | SUBTYPE | MODIFIED RANKIN SCALE | ACUTE ISCHEMIC-STROKE | FOLLOW-UP | PERIPHERAL VASCULAR DISEASE | CARE | ACCESS | CLINICAL NEUROLOGY | Brain Ischemia - complications | Intensive Care Units | Outcome Assessment (Health Care) | Humans | Middle Aged | Cerebral Hemorrhage - mortality | Male | Case-Control Studies | Young Adult | Stroke - etiology | Hospital Units | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Brain Ischemia - mortality | Stroke - mortality | Cerebral Hemorrhage - complications | Cohort Studies
Original Paper | Stroke unit | Mobile stroke system | Intensive care unit | Acute management of stroke | SUBTYPE | MODIFIED RANKIN SCALE | ACUTE ISCHEMIC-STROKE | FOLLOW-UP | PERIPHERAL VASCULAR DISEASE | CARE | ACCESS | CLINICAL NEUROLOGY | Brain Ischemia - complications | Intensive Care Units | Outcome Assessment (Health Care) | Humans | Middle Aged | Cerebral Hemorrhage - mortality | Male | Case-Control Studies | Young Adult | Stroke - etiology | Hospital Units | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Brain Ischemia - mortality | Stroke - mortality | Cerebral Hemorrhage - complications | Cohort Studies
Journal Article
Sleep Medicine Reviews, ISSN 1087-0792, 06/2019, Volume 45, pp. 127 - 128
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 9/2015, Volume 41, Issue 9, pp. 1601 - 1610
Clinical data on patients with intra-abdominal candidiasis (IAC) is still scarce.We collected data from 13 hospitals in Italy, Spain, Brazil, and Greece over a...
Pediatrics | Antifungal therapy | Emergency Medicine | Mortality | Intensive / Critical Care Medicine | Adequate treatment | Pain Medicine | Pneumology/Respiratory System | Medicine & Public Health | Candida | Anesthesiology | Source control | Abdominal candidiasis | CANDIDEMIA | MANAGEMENT | SUSCEPTIBILITY | GUIDELINES | PERITONITIS | RISK-FACTOR | SEPTIC SHOCK | INFECTION | FLUCONAZOLE | CRITICAL CARE MEDICINE | Prognosis | Risk Assessment | Humans | Middle Aged | Risk Factors | Candidiasis - epidemiology | Candidiasis - mortality | Male | Candidiasis - complications | Abdomen | Shock, Septic - microbiology | Spain | Greece | Candidiasis - drug therapy | Brazil | Female | Italy | Retrospective Studies | Cohort Studies | Causes of | Candidiasis | Diagnosis | Research | Demographic aspects
Pediatrics | Antifungal therapy | Emergency Medicine | Mortality | Intensive / Critical Care Medicine | Adequate treatment | Pain Medicine | Pneumology/Respiratory System | Medicine & Public Health | Candida | Anesthesiology | Source control | Abdominal candidiasis | CANDIDEMIA | MANAGEMENT | SUSCEPTIBILITY | GUIDELINES | PERITONITIS | RISK-FACTOR | SEPTIC SHOCK | INFECTION | FLUCONAZOLE | CRITICAL CARE MEDICINE | Prognosis | Risk Assessment | Humans | Middle Aged | Risk Factors | Candidiasis - epidemiology | Candidiasis - mortality | Male | Candidiasis - complications | Abdomen | Shock, Septic - microbiology | Spain | Greece | Candidiasis - drug therapy | Brazil | Female | Italy | Retrospective Studies | Cohort Studies | Causes of | Candidiasis | Diagnosis | Research | Demographic aspects
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 11, pp. 1068 - 1075
Summary Background Narcolepsy is characterised by excessive daytime sleepiness (EDS) and cataplexy. Histamine neurons are crucial to maintain wakefulness. We...
Neurology | SLEEP | PRACTICE PARAMETERS | DOPAMINE | SOMNOLENCE | HISTAMINE H-3 RECEPTOR | MICE | CSF HISTAMINE | HYPERSOMNIA | BRAIN | CLINICAL NEUROLOGY | WAKEFULNESS | Severity of Illness Index | Piperidines - administration & dosage | Benzhydryl Compounds - administration & dosage | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Histamine Agonists - administration & dosage | Young Adult | Benzhydryl Compounds - adverse effects | Modafinil | Piperidines - pharmacology | Piperidines - adverse effects | Placebos | Adult | Female | Histamine Agonists - adverse effects | Benzhydryl Compounds - pharmacology | Histamine Agonists - pharmacology | Wakefulness-Promoting Agents - adverse effects | Narcolepsy - drug therapy | Wakefulness-Promoting Agents - administration & dosage | Wakefulness-Promoting Agents - pharmacology | Clinical trials | Histamine | Care and treatment | Narcolepsy | Sleep
Neurology | SLEEP | PRACTICE PARAMETERS | DOPAMINE | SOMNOLENCE | HISTAMINE H-3 RECEPTOR | MICE | CSF HISTAMINE | HYPERSOMNIA | BRAIN | CLINICAL NEUROLOGY | WAKEFULNESS | Severity of Illness Index | Piperidines - administration & dosage | Benzhydryl Compounds - administration & dosage | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Histamine Agonists - administration & dosage | Young Adult | Benzhydryl Compounds - adverse effects | Modafinil | Piperidines - pharmacology | Piperidines - adverse effects | Placebos | Adult | Female | Histamine Agonists - adverse effects | Benzhydryl Compounds - pharmacology | Histamine Agonists - pharmacology | Wakefulness-Promoting Agents - adverse effects | Narcolepsy - drug therapy | Wakefulness-Promoting Agents - administration & dosage | Wakefulness-Promoting Agents - pharmacology | Clinical trials | Histamine | Care and treatment | Narcolepsy | Sleep
Journal Article
Frontiers in Aging Neuroscience, ISSN 1663-4365, 2016, Volume 8
Journal Article
PLOS ONE, ISSN 1932-6203, 12/2017, Volume 12, Issue 12, p. e0190027
Objectives Sleep-wake disturbances (SWD) are frequent in Parkinson's disease (PD). The effect of deep brain stimulation (DBS) on SWD is poorly known. In this...
NUCLEUS STIMULATION | DAYTIME SLEEPINESS | APATHY | CRITIQUE | DISTURBANCES | RECOMMENDATIONS | BILATERAL STIMULATION | MULTIDISCIPLINARY SCIENCES | SCALES | FOLLOW-UP | WAKEFULNESS TEST | Medicine, Experimental | Medical research | Sleep | Analysis
NUCLEUS STIMULATION | DAYTIME SLEEPINESS | APATHY | CRITIQUE | DISTURBANCES | RECOMMENDATIONS | BILATERAL STIMULATION | MULTIDISCIPLINARY SCIENCES | SCALES | FOLLOW-UP | WAKEFULNESS TEST | Medicine, Experimental | Medical research | Sleep | Analysis
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2012, Volume 55, Issue 7, pp. 943 - 950
Background. The spread of Klebsiella pneumoniae (Kp) strains that produce K. pneumoniae carbapenemases (KPCs) has become a significant problem, and treatment...
Health outcomes | Microbial sensitivity tests | Infectious diseases | Antimicrobials | Mortality | Septic shock | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Blood | MOLECULAR CHARACTERIZATION | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | EMERGENCE | KPC-2 CARBAPENEMASE | NEW-YORK-CITY | ANTIMICROBIAL TREATMENT | HOSPITALIZED ADULTS | OUTCOMES | SPREAD | EPIDEMIOLOGY | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Bacteremia - mortality | Male | Bacterial Proteins - secretion | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Risk Factors | Decision Support Techniques | Bacteremia - diagnosis | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - diagnosis | Italy | Klebsiella Infections - mortality | Aged | Cohort Studies | Klebsiella infections | Blood-borne diseases | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy
Health outcomes | Microbial sensitivity tests | Infectious diseases | Antimicrobials | Mortality | Septic shock | Infections | ARTICLES AND COMMENTARIES | Carbapenems | Klebsiella pneumoniae | Blood | MOLECULAR CHARACTERIZATION | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | EMERGENCE | KPC-2 CARBAPENEMASE | NEW-YORK-CITY | ANTIMICROBIAL TREATMENT | HOSPITALIZED ADULTS | OUTCOMES | SPREAD | EPIDEMIOLOGY | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Prognosis | Humans | Middle Aged | Bacteremia - mortality | Male | Bacterial Proteins - secretion | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Risk Factors | Decision Support Techniques | Bacteremia - diagnosis | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Survival Analysis | Klebsiella Infections - diagnosis | Italy | Klebsiella Infections - mortality | Aged | Cohort Studies | Klebsiella infections | Blood-borne diseases | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Drug therapy
Journal Article
Neuroradiology, ISSN 0028-3940, 6/2012, Volume 54, Issue 6, pp. 573 - 578
Diffusion-weighted imaging (DWI) has become a reference MRI technique for the evaluation of neurological disorders. Few publications have investigated the...
Neurology | Neurosciences | Multiple sclerosis | Medicine & Public Health | Demyelination | MRI | Inflammatory myelopathy | DWI | Neurosurgery | Imaging / Radiology | Neuroradiology | SPINAL-CORD | TIME-COURSE | ANISOTROPY | NEUROIMAGING | LESIONS | CLINICAL NEUROLOGY | APPEARING WHITE-MATTER | MULTIPLE-SCLEROSIS | COEFFICIENT | DISABILITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | WATER | Acute Disease | Reproducibility of Results | Spinal Cord - pathology | Humans | Middle Aged | Sensitivity and Specificity | Adult | Female | Male | Spinal Cord Diseases - pathology | Demyelinating Diseases - pathology | Diffusion Magnetic Resonance Imaging - methods | Nervous system diseases | Diagnostic imaging | Nuclear magnetic resonance--NMR | Spine | Neurological disorders | Neuroimaging | Neurological diseases | Spinal cord | Magnetic resonance imaging | Central nervous system diseases | Inflammation | Diffusion coefficient
Neurology | Neurosciences | Multiple sclerosis | Medicine & Public Health | Demyelination | MRI | Inflammatory myelopathy | DWI | Neurosurgery | Imaging / Radiology | Neuroradiology | SPINAL-CORD | TIME-COURSE | ANISOTROPY | NEUROIMAGING | LESIONS | CLINICAL NEUROLOGY | APPEARING WHITE-MATTER | MULTIPLE-SCLEROSIS | COEFFICIENT | DISABILITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | WATER | Acute Disease | Reproducibility of Results | Spinal Cord - pathology | Humans | Middle Aged | Sensitivity and Specificity | Adult | Female | Male | Spinal Cord Diseases - pathology | Demyelinating Diseases - pathology | Diffusion Magnetic Resonance Imaging - methods | Nervous system diseases | Diagnostic imaging | Nuclear magnetic resonance--NMR | Spine | Neurological disorders | Neuroimaging | Neurological diseases | Spinal cord | Magnetic resonance imaging | Central nervous system diseases | Inflammation | Diffusion coefficient
Journal Article
12.
Full Text
Awareness of stroke risk after TIA in Swiss general practitioners and hospital physicians
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135885
Background Transient ischemic attacks (TIA) are stroke warning signs and emergency situations, and, if immediately investigated, doctors can intervene to...
QUESTIONNAIRE SURVEY | MANAGEMENT | PRIMARY-CARE-PHYSICIANS | TRANSIENT ISCHEMIC ATTACK | MULTIDISCIPLINARY SCIENCES | MINOR STROKE | Surveys | Physicians (General practice) | Ischemia | Medicine, Preventive | Risk factors | Preventive health services | Elderly people | Physicians | Colleges & universities | Emergency medical care | Delay | Medical referrals | Risk assessment | Population | Public schools | Medical personnel | Stroke | Internal medicine | Health risks | Risk taking | Emergency warning programs | Patients | Primary care | Long-term care | Catchment areas | Doctors | Family physicians | Medicine | Studies | Neurology | Hospitals | Elderly | Geriatrics
QUESTIONNAIRE SURVEY | MANAGEMENT | PRIMARY-CARE-PHYSICIANS | TRANSIENT ISCHEMIC ATTACK | MULTIDISCIPLINARY SCIENCES | MINOR STROKE | Surveys | Physicians (General practice) | Ischemia | Medicine, Preventive | Risk factors | Preventive health services | Elderly people | Physicians | Colleges & universities | Emergency medical care | Delay | Medical referrals | Risk assessment | Population | Public schools | Medical personnel | Stroke | Internal medicine | Health risks | Risk taking | Emergency warning programs | Patients | Primary care | Long-term care | Catchment areas | Doctors | Family physicians | Medicine | Studies | Neurology | Hospitals | Elderly | Geriatrics
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 8/2013, Volume 57, Issue 3, pp. 349 - 358
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only...
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects
Intensive care units | Health outcomes | Acinetobacter baumannii | Microbial sensitivity tests | Mortality | Acinetobacter | Infections | Hospitalization | ARTICLES AND COMMENTARIES | Dosage | Arm | Treatment efficacy | Ventilator-associated pneumonia | Antimicrobial therapy | Treatment safety | INFECTIOUS DISEASES | MULTIDRUG-RESISTANT | ventilator-associated pneumonia | antimicrobial therapy | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | NOSOCOMIAL INFECTIONS | treatment safety | GRAM-NEGATIVE BACTERIA | GLOBAL SPREAD | mortality | MULTIRESISTANT | MOLECULAR EPIDEMIOLOGY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | treatment efficacy | NEPHROTOXICITY | Length of Stay | Intensive Care Units | Tertiary Care Centers | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Critical Illness | Male | Treatment Outcome | Acinetobacter Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Drug Resistance, Multiple, Bacterial | Survival Analysis | Aged, 80 and over | Acinetobacter baumannii - isolation & purification | Adult | Colistin - therapeutic use | Female | Rifampin - therapeutic use | Aged | Acinetobacter baumannii - drug effects | Usage | Colistin | Patient outcomes | Dosage and administration | Drug therapy, Combination | Drug therapy | Rifampin | Health aspects
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2011, Volume 6, Issue 9, p. e24198
Candida is an important cause of bloodstream infections (BSI), causing significant mortality and morbidity in health care settings. From January 2008 to...
UNITED-STATES | MORTALITY | RISK-FACTORS | THERAPY | BIOLOGY | SURVEILLANCE | SECULAR TRENDS | CRITICALLY-ILL PATIENTS | BLOOD-STREAM INFECTIONS | INTENSIVE-CARE | FLUCONAZOLE | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Humans | Middle Aged | Amphotericin B - pharmacology | Candidiasis - epidemiology | Male | Treatment Outcome | Pyrimidines - pharmacology | Communicable Disease Control - methods | Cross Infection - drug therapy | Itraconazole - pharmacology | Triazoles - pharmacology | Hospitals | Candidiasis - drug therapy | Voriconazole | Female | Italy | Aged | Lipopeptides | Echinocandins - pharmacology | Cross Infection - epidemiology | Medicine, Experimental | Medical research | Health aspects | Epidemiology | Mortality | Antifungal agents | Health care | Nosocomial infection | Intensive care | Fungicides | Transplants & implants | Laboratories | Fungal infections | Patients | Morbidity | Risk factors | Infectious diseases | Surveillance | Medical prognosis | Candidemia | Cancer | Neutropenia
UNITED-STATES | MORTALITY | RISK-FACTORS | THERAPY | BIOLOGY | SURVEILLANCE | SECULAR TRENDS | CRITICALLY-ILL PATIENTS | BLOOD-STREAM INFECTIONS | INTENSIVE-CARE | FLUCONAZOLE | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Humans | Middle Aged | Amphotericin B - pharmacology | Candidiasis - epidemiology | Male | Treatment Outcome | Pyrimidines - pharmacology | Communicable Disease Control - methods | Cross Infection - drug therapy | Itraconazole - pharmacology | Triazoles - pharmacology | Hospitals | Candidiasis - drug therapy | Voriconazole | Female | Italy | Aged | Lipopeptides | Echinocandins - pharmacology | Cross Infection - epidemiology | Medicine, Experimental | Medical research | Health aspects | Epidemiology | Mortality | Antifungal agents | Health care | Nosocomial infection | Intensive care | Fungicides | Transplants & implants | Laboratories | Fungal infections | Patients | Morbidity | Risk factors | Infectious diseases | Surveillance | Medical prognosis | Candidemia | Cancer | Neutropenia
Journal Article
15.
Full Text
Pedunculopontine nucleus: An integrative view with implications on Deep Brain Stimulation
Neurobiology of Disease, ISSN 0969-9961, 08/2019, Volume 128, pp. 75 - 85
The pedunculopontine nucleus (PPN) is a reticular nucleus located in the mesencephalic and upper pontine tegmentum. Initially, characterized by its predominant...
Nucleus | Review | Pedunculopontine | Deep Brain Stimulation | Gait disorders | LATERODORSAL TEGMENTAL NUCLEI | BASAL-GANGLIA | ORAL MOTOR NUCLEI | SUBSTANTIA-NIGRA | NEUROSCIENCES | RETICULAR-FORMATION | SUBTHALAMIC NUCLEUS | CHOLINERGIC NEURONS | LOCUS-COERULEUS | STEM MULTISYNAPTIC CONNECTIONS | PONTOMESENCEPHALIC TEGMENTUM | Animal experimentation | Neurons | Movement disorders
Nucleus | Review | Pedunculopontine | Deep Brain Stimulation | Gait disorders | LATERODORSAL TEGMENTAL NUCLEI | BASAL-GANGLIA | ORAL MOTOR NUCLEI | SUBSTANTIA-NIGRA | NEUROSCIENCES | RETICULAR-FORMATION | SUBTHALAMIC NUCLEUS | CHOLINERGIC NEURONS | LOCUS-COERULEUS | STEM MULTISYNAPTIC CONNECTIONS | PONTOMESENCEPHALIC TEGMENTUM | Animal experimentation | Neurons | Movement disorders
Journal Article